This trial is terminated!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Keratoconus, Corneal Diseases, Eye Diseases or Photosensitizing Agents
and you are
over 8
years old
This is a second phase trial assessing
efficacy and side effects of the new treatment.
Show me locations

The purpose

This study will assess changes in visual acuity and corneal symmetry after corneal collagen cross-linking (CXL) of asymmetric corneas.

Provided treatments

  • Compound Product: CXLO Corneal Strengthening Solution and UVA Illumination Device

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT03029104. The sponsor of the trial is Cxlusa and it is looking for 2228 volunteers for the current phase.
Official trial title:
Collagen Cross-Linking With Ultraviolet-A in Asymmetric Corneas